Delivery Order SPE2DB20D2002-SPE2DB23FL65G
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,072.54 firm fixed-price delivery order is for the supply of 1,200,000 units of Bicillin L-A, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of July 6, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award, valued at $1,118.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a medication, with an ultimate completion date of April 28, 2023. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,138.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a completion date of February 8, 2023. This contract was awarded as a Firm Fixed Price Delivery Order and did not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,145.18 firm fixed-price delivery order is for the supply of 1,200,000 units of Bicillin L-A, a prescription medication, with a completion date of November 7, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,200,000 units of Bicillin L-A, a medication, under a Firm Fixed Price Delivery Order contract valued at $1,670.23. The contract has an ultimate completion date of September 27, 2021 and was awarded on September 24, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $12,927.75 firm fixed-price delivery order is for the supply of 1,200,000 units of Bicillin L-A, a prescription medication, with a completion date of January 30, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,226.75 firm fixed-price delivery order is for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a performance period through April 3, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, worth $1,105.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a 2ML injectable medication, with a completion date of December 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Bicillin L-A, a 1,200,000 unit, 2ml medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for $1,175.24. The contract has an ultimate completion date of January 26, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 2,400,000 units of Bicillin L-A, a pharmaceutical product. The $6,888.04 fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 7, 2022. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB23FL65GDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,870.48 firm fixed-price delivery order is for 1,200,000 units of Bicillin L-A, a medication used to treat various infections. The award has an ultimate completion date of August 29, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable the efficient procurement of essential pharmaceutical and medical commodities by various federal agencies. The contract award does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 8/28/23 |